Financhill
Back

Blueprint Medicines Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight selling pressure.

Blueprint Medicines Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 128.08 Buy
20-day SMA: 118.35 Buy
50-day SMA: 102.34 Buy
200-day SMA: 95.74 Buy
8-day EMA: 127.05 Buy
20-day EMA: 120.04 Buy
50-day EMA: 108.59 Buy
200-day EMA: 97.88 Buy

Blueprint Medicines Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.03 Buy
Relative Strength Index (14 RSI): 75.53 Buy
Chaikin Money Flow: -1180116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.99 - 128.61) Buy
Bollinger Bands (100): (85.1 - 113.52) Buy

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Blueprint Medicines Stock

Is Blueprint Medicines Stock a Buy?

BPMC Technical Analysis vs Fundamental Analysis

Buy
52
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines a Buy or a Sell?

Blueprint Medicines Stock Info

Market Cap:
8.3B
Price in USD:
128.12
Share Volume:
3.5M

Blueprint Medicines 52-Week Range

52-Week High:
128.34
52-Week Low:
73.04
Buy
52
Blueprint Medicines (BPMC) is a Buy

Blueprint Medicines Share Price Forecast

Is Blueprint Medicines Stock a Buy?

  • Blueprint Medicines share price is 128.12 while BPMC 8-day exponential moving average is 127.05, which is a Buy signal.
  • The stock price of BPMC is 128.12 while Blueprint Medicines 20-day EMA is 120.04, which makes it a Buy.
  • Blueprint Medicines 50-day exponential moving average is 108.59 while BPMC share price is 128.12, making it a Buy technically.
  • BPMC stock price is 128.12 and Blueprint Medicines 200-day simple moving average is 97.88, creating a Buy signal.

Fundamental Analysis of Blueprint Medicines

Is Blueprint Medicines a good investment?

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

Technical Analysis of Blueprint Medicines

Should I short Blueprint Medicines stock?

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.